Clinical Trials Browser

Phase 3 × Completed × irinotecan sucrosofate × Clear all

NCT04083235 2026-04-20

NAPOLI 3

Phase 3 Completed

770 enrolled 13 charts 1 FDA

Gastrointestinal

Metastatic Adenocarcinoma of the Pancreas

NCT03468335 2025-04-17

PREDICT

Phase 3 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT03088813 2025-02-19

RESILIENT

Phase 3 Completed

491 enrolled 24 charts

Small Cell Lung Carcinoma

NCT01926197 2022-10-28

Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer

Phase 3 Completed

27 enrolled 15 charts

Gastrointestinal

Pancreatic Neoplasms

NCT03665441 2022-10-18

Trybeca-1

Phase 3 Completed

512 enrolled 19 charts

Neoplasms

NCT01494506 2016-06-17

NAPOLI-1

Phase 3 Completed

417 enrolled 20 charts

Gastrointestinal

Pancreatic Neoplasms